Phase 3
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Squamous Cell

Thank you

Trial Information

Inclusion Criteria


- 18 years or older

- Must have had radiation treatment

- Eligible for chemotherapy

- Not eligible for surgery

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Kerstin Menander, MD

Investigator Role:

Study Director

Authority:

United States: Food and Drug Administration

Study ID:

T302

NCT ID:

NCT00041626

Start Date:

Completion Date:

Related Keywords:

  • Carcinoma, Squamous Cell
  • Recurrent Squamous Cell Carcinoma of the Head and Neck
  • Carcinoma
  • Carcinoma, Squamous Cell

Name

Location
Norton Healthcare Pavilion Louisville, Kentucky  40202
Mary Crowley Medical Research Center Dallas, Texas  75246
University of Arkansas Little Rock, Arkansas  72202
Unversity of Colorado Cancer Center Aurora, Colorado  80045
WJB Dorn VA Medical Center Columbia, South Carolina  29209
University of Miami Hospital and Sylvester Comprehensive Cancer Center Miami, Florida  33136
Center Center of GBMC Baltimore, Maryland  21204
University of Texas, MD Andersen Cancer Center Houston, Texas  77030